{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:14:07Z","timestamp":1793060047650,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11097-w","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T04:14:25Z","timestamp":1747109665000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Chemotherapy-induced febrile neutropenia followed by acute hepatitis E virus infection in rectal cancer patient with synchronous liver and lung metastasis: a case report"],"prefix":"10.1186","volume":"25","author":[{"given":"Dongdong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"issue":"5","key":"11097_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/01.NAJ.0000931888.96896.a1","volume":"123","author":"AM Foley","year":"2023","unstructured":"Foley AM, Hoffman M. CE: Febrile Neutropenia in the Chemotherapy Patient. Am J Nurs. 2023;123(5):36\u201342. https:\/\/doi.org\/10.1097\/01.NAJ.0000931888.96896.a1.","journal-title":"Am J Nurs"},{"issue":"8","key":"11097_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/01.JAA.0000000000000054","volume":"37","author":"J Cossey","year":"2024","unstructured":"Cossey J, Cote MCB. Evaluation and management of febrile neutropenia in patients with cancer. Jaapa. 2024;37(8):16\u201320. https:\/\/doi.org\/10.1097\/01.JAA.0000000000000054.","journal-title":"Jaapa"},{"issue":"2","key":"11097_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/TME.0000000000000399","volume":"44","author":"S Barr\u00e9","year":"2022","unstructured":"Barr\u00e9 S, McElwee J, Calhoun C, Weant KA, Maldonado A, Bell CM. Review of Hematological and Oncological Emergencies. Adv Emerg Nurs J. 2022;44(2):84\u2013102. https:\/\/doi.org\/10.1097\/TME.0000000000000399.","journal-title":"Adv Emerg Nurs J"},{"key":"11097_CR4","doi-asserted-by":"publisher","unstructured":"Averbuch, D., et al., European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica, 2013. 98(12): p. 1826\u20131835. https:\/\/doi.org\/10.3324\/haematol.2013.091025","DOI":"10.3324\/haematol.2013.091025"},{"issue":"Suppl 5","key":"11097_CR5","doi-asserted-by":"publisher","first-page":"v252","DOI":"10.1093\/annonc\/mdq196","volume":"21","author":"J de Naurois","year":"2010","unstructured":"de Naurois J, et al. Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Ann Oncol. 2010;21(Suppl 5):v252\u20136. https:\/\/doi.org\/10.1093\/annonc\/mdq196.","journal-title":"Ann Oncol"},{"key":"11097_CR6","doi-asserted-by":"publisher","unstructured":"Nagoba, B.S. and A.S. Rayate, Hepatitis E virus infections. World Journal of Virology, 2024. 13(2). https:\/\/doi.org\/10.5501\/wjv.v13.i2.90951","DOI":"10.5501\/wjv.v13.i2.90951"},{"key":"11097_CR7","doi-asserted-by":"publisher","unstructured":"Orosz, L., et al., Pathogenesis and clinical features of severe hepatitis E virus infection. World Journal of Virology, 2024. 13(2). https:\/\/doi.org\/10.5501\/wjv.v13.i2.91580","DOI":"10.5501\/wjv.v13.i2.91580"},{"issue":"1","key":"11097_CR8","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s12879-024-09349-2","volume":"24","author":"UK Mirzaev","year":"2024","unstructured":"Mirzaev UK, et al. Systematic review and meta-analysis of hepatitis E seroprevalence in Southeast Asia: a comprehensive assessment of epidemiological patterns. BMC Infect Dis. 2024;24(1):525. https:\/\/doi.org\/10.1186\/s12879-024-09349-2.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"11097_CR9","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1186\/s12889-023-15792-8","volume":"23","author":"FH Al-Shimari","year":"2023","unstructured":"Al-Shimari FH, et al. Systematic review of global hepatitis E outbreaks to inform response and coordination initiatives. BMC Public Health. 2023;23(1):1120. https:\/\/doi.org\/10.1186\/s12889-023-15792-8.","journal-title":"BMC Public Health"},{"issue":"3","key":"11097_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2023-257234","volume":"17","author":"T Gupta","year":"2024","unstructured":"Gupta T, Dhiman S, Sharma A. Menace of hepatitis E in pregnancy: unleashing the threat of fulminant liver failure. BMJ Case Rep. 2024;17(3): e257234. https:\/\/doi.org\/10.1136\/bcr-2023-257234.","journal-title":"BMJ Case Rep"},{"issue":"3","key":"11097_CR11","doi-asserted-by":"publisher","DOI":"10.14309\/crj.0000000000001308","volume":"11","author":"I Mohamed","year":"2024","unstructured":"Mohamed I, Sanders K, Hillebrand DJ. Chronic Hepatitis E Virus Manifesting as Elevated Transaminases in a Heart Transplant Patient. ACG Case Rep J. 2024;11(3): e01308. https:\/\/doi.org\/10.14309\/crj.0000000000001308.","journal-title":"ACG Case Rep J"},{"issue":"3","key":"11097_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000530802","volume":"68","author":"H Okumura","year":"2023","unstructured":"Okumura H, Miyamoto A, Suzuki F, Takaya H. Acute Hepatitis E Infection during Chemotherapy for Lung Cancer: A Case Report. Chemotherapy. 2023;68(3):155\u20139. https:\/\/doi.org\/10.1159\/000530802.","journal-title":"Chemotherapy"},{"key":"11097_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jclinepi.2017.04.026","volume":"89","author":"DS Riley","year":"2017","unstructured":"Riley DS, Barber MS, Kienle GS, et al. CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol. 2017;89:218\u201335. https:\/\/doi.org\/10.1016\/j.jclinepi.2017.04.026.","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"11097_CR14","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/oncolo\/oyac074","volume":"27","author":"R Boccia","year":"2022","unstructured":"Boccia R, et al. Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed? Oncologist. 2022;27(8):625\u201336. https:\/\/doi.org\/10.1093\/oncolo\/oyac074.","journal-title":"Oncologist"},{"key":"11097_CR15","doi-asserted-by":"publisher","unstructured":"Griffiths, E.A., et al., NCCN Guidelines(R) Insights: Hematopoietic Growth Factors, Version 1.2022. J Natl Compr Canc Netw, 2022. 20(5): p. 436\u2013442. https:\/\/doi.org\/10.6004\/jnccn.2022.0026","DOI":"10.6004\/jnccn.2022.0026"},{"issue":"4","key":"11097_CR16","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2011;52(4):e56-93. https:\/\/doi.org\/10.1093\/cid\/cir073.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"11097_CR17","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1200\/JCO.2012.45.8661","volume":"31","author":"CR Flowers","year":"2013","unstructured":"Flowers CR, Seidenfeld J, Bow EJ, et al. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013;31(6):794\u2013810. https:\/\/doi.org\/10.1200\/JCO.2012.45.8661.","journal-title":"J Clin Oncol"},{"issue":"3","key":"11097_CR18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.6004\/jadpro.2023.14.3.4","volume":"14","author":"KC Molina","year":"2023","unstructured":"Molina KC. Best Practices in the Management of Infectious Complications for Patients With Cancer: Management of Febrile Neutropenia. J Adv Pract Oncol. 2023;14(3):201\u20136. https:\/\/doi.org\/10.6004\/jadpro.2023.14.3.4.","journal-title":"J Adv Pract Oncol"},{"key":"11097_CR19","doi-asserted-by":"publisher","unstructured":"Davern, T.J., et al., Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology, 2011. 141(5): p. 1665\u201372 e1\u20139. https:\/\/doi.org\/10.1053\/j.gastro.2011.07.051","DOI":"10.1053\/j.gastro.2011.07.051"},{"issue":"9","key":"11097_CR20","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.14309\/ajg.0000000000001869","volume":"117","author":"RJ Fontana","year":"2022","unstructured":"Fontana RJ, et al. Incidence of Hepatitis E Infection in American Patients With Suspected Drug-Induced Liver Injury Is Low and Declining: The DILIN Prospective Study. Am J Gastroenterol. 2022;117(9):1462\u201370. https:\/\/doi.org\/10.14309\/ajg.0000000000001869.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"11097_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/PAP.0000000000000195","volume":"25","author":"D Lenggenhager","year":"2018","unstructured":"Lenggenhager D, Weber A. An Update on the Clinicopathologic Features and Pathologic Diagnosis of Hepatitis E in Liver Specimens. Adv Anat Pathol. 2018;25(4):273\u201381. https:\/\/doi.org\/10.1097\/PAP.0000000000000195.","journal-title":"Adv Anat Pathol"},{"issue":"3","key":"11097_CR22","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/TP.0b013e3181c4096c","volume":"89","author":"N Kamar","year":"2010","unstructured":"Kamar N, et al. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation. 2010;89(3):353\u201360. https:\/\/doi.org\/10.1097\/TP.0b013e3181c4096c.","journal-title":"Transplantation"},{"issue":"6","key":"11097_CR23","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.jhep.2018.03.005","volume":"68","author":"HR Dalton","year":"2018","unstructured":"Dalton HR, et al. EASL Clinical Practice Guidelines on hepatitis E virus infection. J Hepatol. 2018;68(6):1256\u201371. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.005.","journal-title":"J Hepatol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11097-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11097-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11097-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T04:14:26Z","timestamp":1747109666000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11097-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11097"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11097-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"21 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is exempt from ethical approval in our institution, due to the number of cases being less than three.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"693"}}